Concepedia

Safety of Etanercept and Methotrexate in Patients with Rheumatoid Arthritis and Hepatitis C Virus Infection: A Multicenter Randomized Clinical Trial

Florenzo Iannone, G. La Montagna, Gianfilippo Bagnato, Elisa Gremese, Anna Giardina, Giovanni Lapadula

The Journal of Rheumatology · 2014 · 51 citations · 14 references

DOIFull text

Open access

Abstract

This study showed that patients with RA and chronic HCV and mild hepatitis may be successfully treated with etanercept and MTX without increasing the risk of hepatotoxicity and HCV replication. ClinicalTrials.gov Identifier NCT01543594.

References

14

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

K. Visser, Wanruchada Katchamart, Estíbaliz Loza et al. · Annals of the Rheumatic Diseases · 2008 · 485 citations · Full text

Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study

Nizar N. Zein, for the Etanercept Study Group · Journal of Hepatology · 2004 · 249 citations

, , +12

Effect of tumour necrosis factor α antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection

J. R. Peterson · Annals of the Rheumatic Diseases · 2003 · 210 citations · Full text

Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity

Hervé Zylberberg, Anne‐Cécile Rimaniol, Stanislas Pol et al. · Journal of Hepatology · 1999 · 185 citations

, , +16

Anti–tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection

Frank A. Parke, John D. Reveille · Arthritis Care & Research · 2004 · 117 citations